SEC Info - Osiris Therapeutics, Inc. - ‘8-K’ for 1/27/17

SEC Info℠

Home

Help

Please Sign In

Osiris Therapeutics, Inc. – ‘8-K’ for 1/27/17

On: Tuesday, 1/31/17, at 5:04pm ET · For: 1/27/17 · Accession #: 1104659-17-5433 · File #: 1-32966

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/31/17  Osiris Therapeutics, Inc.         8-K:5       1/27/17    1:19K                                    Merrill Corp-MD/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     15K

Filing Submission 0001104659-17-005433 – SGML Text

Original SGML Text submitted by:	Toppan Merrill/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 19K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20170131-170456	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20170131-170456	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20170131-170400	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001104659-17-005433
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		1
<PERIOD>			20170127
<ITEMS>				5.02
<FILING-DATE>			20170131
<DATE-OF-FILING-DATE-CHANGE>	20170131

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		OSIRIS THERAPEUTICS, INC.
<CIK>				0001360886
<ASSIGNED-SIC>			2836
<IRS-NUMBER>			710881115  ⇒ 71-0881115
<STATE-OF-INCORPORATION>	MD
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			001-32966
<FILM-NUMBER>			17561924
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			7015 ALBERT EINSTEIN DRIVE
<CITY>				COLUMBIA
<STATE>				MD
<ZIP>				21046
<PHONE>				443-545-1819
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			7015 ALBERT EINSTEIN DRIVE
<CITY>				COLUMBIA
<STATE>				MD
<ZIP>				21046
</MAIL-ADDRESS>
</FILER>

<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	a17-3543_18k.htm
<DESCRIPTION>	8-K
<TEXT>
<html>
       Show <HTML>: 155 lines (widest: 653 characters) - 18K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001104659-17-005433 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Osiris Therapeutics, Inc. – ‘8-K’ for 1/27/17

On: Tuesday, 1/31/17, at 5:04pm ET · For: 1/27/17 · Accession #: 1104659-17-5433 · File #: 1-32966

Previous ‘8-K’: ‘8-K’ on 1/12/17 for 1/6/17 · Next: ‘8-K’ on 2/10/17 for 2/7/17 · Latest: ‘8-K’ on / for 4/17/19

Current Report — Form 8-KFiling Table of Contents

Current Report — Form 8-K
Filing Table of Contents